Exhibit 2.1
AGREEMENT AND PLAN OF MERGER AND
REORGANIZATION
among:
N UVELO , I NC .,
a Delaware corporation;
D AWN A CQUISITION S UB ,
I NC
.,
a Delaware corporation; and
ARCA BIOPHARMA , I NC .,
a Delaware corporation
Dated as of September 24,
2008
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
SECTION 1. DESCRIPTION OF
TRANSACTION
|
|
1
|
|
1.1
|
|
The
Merger
|
|
1
|
|
1.2
|
|
Effects of the
Merger
|
|
1
|
|
1.3
|
|
Closing;
Effective Times of the Merger
|
|
2
|
|
1.4
|
|
Certificate of
Incorporation and Bylaws; Directors and Officers
|
|
2
|
|
1.5
|
|
Conversion of
Shares; Treatment of Warrants
|
|
2
|
|
1.6
|
|
Closing of the
Company’s Transfer Books
|
|
4
|
|
1.7
|
|
Exchange of
Certificates
|
|
5
|
|
1.8
|
|
Tax
Consequences
|
|
6
|
|
1.9
|
|
Appraisal
Rights
|
|
6
|
|
1.10
|
|
Further
Action
|
|
7
|
|
|
|
|
SECTION 2.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
|
|
7
|
|
2.1
|
|
Subsidiaries;
Due Organization; Etc
|
|
7
|
|
2.2
|
|
Certificate of
Incorporation and Bylaws
|
|
8
|
|
2.3
|
|
Capitalization,
Etc
|
|
8
|
|
2.4
|
|
Financial
Statements; Financial Controls
|
|
10
|
|
2.5
|
|
Absence of
Changes
|
|
11
|
|
2.6
|
|
Title to
Assets
|
|
11
|
|
2.7
|
|
Receivables;
Customers
|
|
12
|
|
2.8
|
|
Equipment;
Leasehold
|
|
12
|
|
2.9
|
|
Intellectual
Property
|
|
12
|
|
2.10
|
|
Contracts
|
|
14
|
|
2.11
|
|
Liabilities
|
|
17
|
|
2.12
|
|
Compliance with
Legal Requirements
|
|
17
|
|
2.13
|
|
Tax
Matters
|
|
19
|
|
2.14
|
|
Employee and
Labor Matters; Benefit Plans
|
|
21
|
|
2.15
|
|
Environmental
Matters
|
|
24
|
|
2.16
|
|
Insurance
|
|
25
|
|
2.17
|
|
Related Party
Transactions
|
|
26
|
|
2.18
|
|
Legal
Proceedings; Orders
|
|
26
|
-i-
Table of Contents
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
2.19
|
|
Authority;
Binding Nature of Agreement
|
|
26
|
|
2.20
|
|
Inapplicability
of Anti-takeover Statutes
|
|
27
|
|
2.21
|
|
Vote
Required
|
|
27
|
|
2.22
|
|
Non-Contravention; Consents
|
|
27
|
|
2.23
|
|
Financial
Advisor
|
|
28
|
|
2.24
|
|
Full
Disclosure
|
|
28
|
|
|
|
|
SECTION 3.
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
|
|
29
|
|
3.1
|
|
Due
Organization
|
|
29
|
|
3.2
|
|
Certificate of
Incorporation and Bylaws
|
|
30
|
|
3.3
|
|
Capitalization,
Etc
|
|
30
|
|
3.4
|
|
SEC Filings;
Financial Statements
|
|
31
|
|
3.5
|
|
Absence of
Changes
|
|
32
|
|
3.6
|
|
Title to
Assets
|
|
32
|
|
3.7
|
|
Equipment;
Leasehold
|
|
33
|
|
3.8
|
|
Intellectual
Property
|
|
33
|
|
3.9
|
|
Material
Contracts
|
|
34
|
|
3.10
|
|
Liabilities
|
|
34
|
|
3.11
|
|
Compliance with
Legal Requirements
|
|
35
|
|
3.12
|
|
Tax
Matters
|
|
36
|
|
3.13
|
|
Employee and
Labor Matters; Benefit Plans
|
|
38
|
|
3.14
|
|
Environmental
Matters
|
|
42
|
|
3.15
|
|
Insurance
|
|
42
|
|
3.16
|
|
Legal
Proceedings; Orders
|
|
43
|
|
3.17
|
|
Authority;
Binding Nature of Agreement
|
|
43
|
|
3.18
|
|
Inapplicability
of Anti-takeover Statutes
|
|
44
|
|
3.19
|
|
Vote
Required
|
|
44
|
|
3.20
|
|
Non-Contravention; Consents
|
|
44
|
|
3.21
|
|
Fairness
Opinion
|
|
45
|
|
3.22
|
|
Financial
Advisor
|
|
45
|
-ii-
Table of Contents
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
3.23
|
|
Valid
Issuance
|
|
45
|
|
3.24
|
|
Full
Disclosure
|
|
45
|
|
|
|
|
SECTION 4.
CERTAIN COVENANTS OF THE PARTIES
|
|
46
|
|
4.1
|
|
Access and
Investigation
|
|
46
|
|
4.2
|
|
Operations
Prior to Closing
|
|
46
|
|
4.3
|
|
Budget
|
|
49
|
|
4.4
|
|
No
Solicitation
|
|
50
|
|
|
|
|
SECTION 5. ADDITIONAL COVENANTS OF THE
PARTIES
|
|
52
|
|
5.1
|
|
Registration
Statement; Proxy Statement/Prospectus
|
|
52
|
|
5.2
|
|
Company
Stockholder Approval
|
|
53
|
|
5.3
|
|
Parent
Stockholders’ Meeting
|
|
54
|
|
5.4
|
|
Stock
Options
|
|
55
|
|
5.5
|
|
Regulatory
Approvals and Related Matters
|
|
56
|
|
5.6
|
|
Disclosure
|
|
58
|
|
5.7
|
|
[Reserved.]
|
|
58
|
|
5.8
|
|
Tax
Matters
|
|
58
|
|
5.9
|
|
Letter of the
Company’s Accountants
|
|
58
|
|
5.10
|
|
Listing
|
|
58
|
|
5.11
|
|
Board of
Directors; Officers
|
|
59
|
|
5.12
|
|
Charter
Amendments
|
|
59
|
|
5.13
|
|
Termination of
Company Stockholder and Other Related Agreements
|
|
59
|
|
5.14
|
|
Section
16b
|
|
59
|
|
|
|
|
SECTION 6.
CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER
SUB
|
|
60
|
|
6.1
|
|
Accuracy of
Company Representations
|
|
60
|
|
6.2
|
|
Performance of
Covenants
|
|
60
|
|
6.3
|
|
Effectiveness
of Registration Statement
|
|
60
|
|
6.4
|
|
Company
Stockholder Approval
|
|
60
|
|
6.5
|
|
Parent
Stockholder Approval
|
|
60
|
|
6.6
|
|
Consents
|
|
60
|
-iii-
Table of Contents
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
6.7
|
|
Documents
|
|
61
|
|
6.8
|
|
No Company
Material Adverse Effect
|
|
61
|
|
6.9
|
|
Other
Governmental Approvals
|
|
62
|
|
6.10
|
|
Listing
|
|
62
|
|
6.11
|
|
No
Restraints
|
|
62
|
|
6.12
|
|
No Governmental
Litigation
|
|
62
|
|
6.13
|
|
Termination of
Company Stockholder and Other Related Agreements
|
|
62
|
|
|
|
|
SECTION 7.
CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY
|
|
63
|
|
7.1
|
|
Accuracy of
Parent Representations
|
|
63
|
|
7.2
|
|
Performance of
Covenants
|
|
63
|
|
7.3
|
|
Effectiveness
of Registration Statement
|
|
63
|
|
7.4
|
|
Company
Stockholder Approval
|
|
63
|
|
7.5
|
|
Parent
Stockholder Approval
|
|
63
|
|
7.6
|
|
Documents
|
|
63
|
|
7.7
|
|
No Parent
Material Adverse Effect
|
|
64
|
|
7.8
|
|
Other
Governmental Approvals
|
|
64
|
|
7.9
|
|
Listing
|
|
64
|
|
7.10
|
|
No
Restraints
|
|
64
|
|
7.11
|
|
No Governmental
Litigation
|
|
64
|
|
|
|
|
SECTION 8.
TERMINATION
|
|
65
|
|
8.1
|
|
Termination
|
|
65
|
|
8.2
|
|
Effect of
Termination
|
|
67
|
|
8.3
|
|
Expenses;
Termination Fees
|
|
67
|
|
|
|
|
SECTION 9.
MISCELLANEOUS PROVISIONS
|
|
68
|
|
9.1
|
|
Amendment
|
|
68
|
|
9.2
|
|
Waiver
|
|
68
|
|
9.3
|
|
No Survival of
Representations and Warranties
|
|
69
|
|
9.4
|
|
Entire
Agreement; Counterparts; Exchanges by Facsimile or Electronic
Delivery
|
|
69
|
|
9.5
|
|
Applicable Law;
Jurisdiction
|
|
69
|
-iv-
Table of Contents
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
9.6
|
|
Disclosure
Schedules
|
|
69
|
|
9.7
|
|
Attorneys’ Fees
|
|
69
|
|
9.8
|
|
Assignability;
No Third Party Rights
|
|
69
|
|
9.9
|
|
Notices
|
|
70
|
|
9.10
|
|
Cooperation
|
|
71
|
|
9.11
|
|
Severability
|
|
71
|
|
9.12
|
|
Construction
|
|
71
|
-v-
EXECUTION VERSION
AGREEMENT AND PLAN OF MERGER AND
REORGANIZATION
T HIS A GREEMENT AND P LAN OF M ERGER AND R EORGANIZATION (“ Agreement ”) is made and
entered into as of September 24, 2008 (the “
Execution Date ”), by and among: N
UVELO , I NC . , a
Delaware corporation (“ Parent ”);
D AWN
A CQUISITION S UB ,
I NC
., a Delaware corporation and a
wholly-owned subsidiary of Parent (“ Merger Sub
”); and ARCA BIOPHARMA , I NC . , a
Delaware corporation (the “ Company ”). Certain
capitalized terms used in this Agreement are defined in Exhibit
A .
R ECITALS
A. Parent, Merger Sub and the Company intend to
effect a merger of Merger Sub into the Company in accordance with
this Agreement and the DGCL (the “ Merger ”).
Upon consummation of the Merger, Merger Sub will cease to exist,
and the Company (as the Surviving Corporation) will become a
wholly-owned subsidiary of Parent.
B. It is intended that, for United States federal
income tax purposes, the Merger shall qualify as a reorganization
within the meaning of Section 368(a) of the Code.
C. The respective boards of directors of Parent,
Merger Sub and the Company have approved this Agreement and the
Merger and contemporaneously with the execution of this Agreement
certain stockholders of the Company have executed voting agreements
pursuant to which such stockholders have agreed to vote in favor of
the Merger through the Company Written Consent (the “
Company Voting Agreements ”) and certain stockholders
of Parent have executed voting agreements pursuant to which such
stockholders have agreed to vote in favor of the issuance of Parent
Common Stock in the Merger and the Charter Amendment at the Parent
Stockholders’ Meeting.
A GREEMENT
The parties to this Agreement,
intending to be legally bound, agree as follows:
SECTION 1. D
ESCRIPTION
OF T RANSACTION
1.1 The Merger . Upon the terms and subject
to the conditions set forth in this Agreement, at the Effective
Time (as defined in Section 1.3), Merger Sub shall be merged
with and into the Company. By virtue of the Merger, at the
Effective Time, the separate existence of Merger Sub shall cease
and the Company shall continue as the surviving corporation in the
Merger (the “ Surviving Corporation
”).
1.2 Effects of the
Merger . The Merger shall
have the effects set forth in this Agreement and in the applicable
provisions of the DGCL.
1.3 Closing; Effective Times of the Merger
.
(a) The consummation of the Contemplated
Transactions (the “ Closing ”) shall take place
at the offices of Cooley Godward Kronish LLP , 3175
Hanover Street, Palo Alto, California, on a date to be designated
by Parent, which shall be no later than the fifth business day
after the satisfaction or waiver of the last to be satisfied or
waived of the conditions set forth in Sections 6 and 7 (other than
conditions which by their nature are to be satisfied at the
Closing, but subject to the satisfaction or waiver of each of such
conditions). The date on which the Closing actually takes place is
referred to as the “ Closing Date .”
(b) Subject to the provisions of this Agreement, in
order to effect the Merger, a certificate of merger satisfying the
applicable requirements of the DGCL shall be duly executed by the
Company and concurrently with or as soon as practicable following
the Closing shall be filed with the Secretary of State of the State
of Delaware. The Merger shall become effective at the time of the
filing of such certificate of merger with the Secretary of State of
the State of Delaware or at such later time as may be designated by
Parent and specified in such certificate of merger (the time as of
which the Merger becomes effective being referred to as the “
Effective Time ”).
1.4 Certificate of Incorporation and Bylaws;
Directors and Officers . Unless otherwise determined by Parent
prior to the Effective Time:
(a) the Certificate of Incorporation of the
Surviving Corporation shall be amended and restated immediately
after the Effective Time to conform to Exhibit B
;
(b) the Bylaws of the Surviving Corporation shall be
amended and restated as of the Effective Time to conform to the
Bylaws of Merger Sub as in effect immediately prior to the
Effective Time; and
(c) the directors and officers of the Surviving
Corporation immediately after the Effective Time shall be the
respective individuals who are listed as directors and officers of
the Company on Schedule 1.4(c).
1.5 Conversion of Shares; Treatment of
Warrants .
(a) At the Effective Time, by virtue of the Merger
and without any further action on the part of Parent, Merger Sub,
the Company or any stockholder of the Company:
(i) any shares of Company Capital Stock held by any
wholly-owned Subsidiary of the Company immediately prior to the
Effective Time (or held in the Company’s treasury) shall be
canceled and retired and shall cease to exist, and no consideration
shall be delivered in exchange therefor;
(ii) any shares of Company Capital Stock held by
Parent, Merger Sub or any other wholly-owned Subsidiary of Parent
immediately prior to the Effective Time shall be canceled and
retired and shall cease to exist, and no consideration shall be
delivered in exchange therefor;
2.
(iii) except as provided in Section 1.5(a)(i) and
(ii) above and subject to Sections 1.5(b), 1.5(c), 1.6, 1.7
and 1.9, each share of Company Capital Stock outstanding
immediately prior to the Effective Time shall be converted into the
right to receive a number of shares of Parent Common Stock equal to
the Exchange Ratio (as defined below and as determined in
accordance with the methodology reflected in the spreadsheet
attached hereto as Schedule 1.5(a)(iii) (the “
Spreadsheet ”)).
(1) The “ Company Share Value ”
shall equal the product of (x) Parent Trading Price
multiplied by (y) the Exchange Ratio.
(2) The “ Exchange Ratio ” shall
be determined as of immediately prior to the Effective Time and
shall equal (x) 109,009,278 divided by (y) the sum
of (A) the number of shares of Company Common Stock issued and
outstanding immediately prior to the Effective Time, (B) the
number of shares of Company Common Stock issuable upon the
conversion of each share of Company Preferred Stock issued and
outstanding immediately prior to the Effective Time (as calculated
in accordance with the Company’s certificate of incorporation
in effect immediately prior to the Effective Time), (C) the
number of Treasury Method Shares of Company Common Stock
Outstanding (as defined below) (which it is agreed shall be
calculated to at least five decimal places), and (D) the
number of shares of Company Common Stock issuable pursuant to or
upon conversion of any convertible notes or other rights
outstanding as of immediately prior to the Effective Time (whether
or not currently exercisable) to acquire shares of Company Capital
Stock, including the notes issued pursuant to the Note
Purchase Agreement (as defined below) and the Company Warrants
issued pursuant to the Note Purchase Agreement but excluding
other Company Warrants and Company Options, or issuable upon
conversion of any Company Preferred Stock issuable pursuant to or
upon conversion of any convertible notes or other rights
outstanding as of immediately prior to Effective Time (as
calculated in accordance with the Company’s certificate of
incorporation in effect immediately prior to the Effective
Time).
(3) The “ Parent Trading Price ”
shall equal the average closing price of the Parent Common Stock on
the Nasdaq Market for the five consecutive trading days immediately
preceding (but not including) the date that includes the Effective
Time.
(4) The “ Treasury Method Shares of Company
Common Stock Outstanding ” shall equal (x) the
product of the number of shares of Company Common Stock underlying
each Company Option and Company Warrant (other than Company
Warrants issued in connection with the Note Purchase Agreement (as
defined below)) that is outstanding and unexercised as of
immediately prior to the Effective Time multiplied by the
difference between (A) the Company Share Value and
(B) the per share exercise price for each such Company Option
and Company Warrant that is outstanding and unexercised as of
immediately prior to the Effective Time; divided by
(y) the Company Share Value, provided, however that for
purposes of greater certainty each Company Option and Company
Warrant that has a per share exercise price that is greater than or
equal to the Company Share Value as of the Effective Time shall be
ignored for purposes of calculating the Treasury Method Shares of
Company Common Stock Outstanding.
(5) The Exchange Ratio is sometimes also referred to
herein as the “ Merger Consideration.
”
3.
(iv) each share of the Common Stock, $0.001 par value
per share, of Merger Sub outstanding immediately prior to the
Effective Time shall be converted into one share of common stock of
the Surviving Corporation.
(b) If, during the period from the date of this
Agreement through the Effective Time, the outstanding shares of
Parent Common Stock are changed into a different number or class of
shares by reason of any stock split, division or subdivision of
shares, stock dividend, reverse stock split, consolidation of
shares, reclassification, recapitalization or other similar
transaction, or if a stock dividend is declared by Parent during
such period, or a record date with respect to any such event shall
occur during such period, then appropriate adjustments shall be
made to the formula used to calculate the Exchange Ratio,
including, but not limited to, the number 109,009,278 in
Section 1.5(a)(iii)(2).
(c) No fractional shares of Parent Common Stock
shall be issued in connection with the Merger, and no certificates
or scrip for any such fractional shares shall be issued. Any holder
of Company Capital Stock who would otherwise be entitled to receive
a fraction of a share of Parent Common Stock (after aggregating all
fractional shares of Parent Common Stock issuable to such holder)
shall, in lieu of such fraction of a share and upon surrender of
such holder’s Company Stock Certificate(s) (as defined in
Section 1.6) be paid in cash the dollar amount (rounded to the
nearest whole cent), without interest, determined by multiplying
such fraction by the closing price of a share of Parent Common
Stock on the Nasdaq Market on the date the Merger becomes
effective.
(d) Each Company Warrant outstanding at the
Effective Time shall be assumed by Parent to the extent not
exercised prior to the Closing. At the Effective Time, each Company
Warrant shall be converted into a warrant to acquire that number of
shares of Parent Common Stock equal to the product of (x) the
number of shares of Company Capital Stock subject to such Company
Warrant by (y) Exchange Ratio, rounded down to the nearest
whole share of Parent Common Stock. Each Company Warrant shall have
a purchase price per share of Parent Common Stock equal to the
quotient obtained by dividing (x) the per share purchase price
of Company Capital Stock subject to such Company Warrant by
(y) the Exchange Ratio rounded up to the nearest whole cent.
Each Company Warrant shall otherwise be subject to the same terms
and conditions (including as to vesting and exercisability) as were
applicable under the respective Company Warrant immediately prior
to the Effective Time.
1.6 Closing of the
Company’s Transfer Books . At the Effective Time: (a) all shares of
Company Capital Stock outstanding immediately prior to the
Effective Time shall automatically be canceled and retired and
shall cease to exist, and all holders of certificates representing
shares of Company Capital Stock that were outstanding immediately
prior to the Effective Time shall cease to have any rights as
stockholders of the Company; and (b) the stock transfer books
of the Company shall be closed with respect to all shares of
Company Capital Stock outstanding immediately prior to the
Effective Time. No further transfer of any such shares of Company
Capital Stock shall be made on such stock transfer books after the
Effective Time. If, after the Effective Time, a valid certificate
previously representing any shares of Company Capital Stock
outstanding immediately prior to the Effective Time (a “
Company Stock Certificate ”) is presented to the
Exchange Agent (as defined in Section 1.7) or to the Surviving
Corporation or Parent, such Company Stock Certificate shall be
canceled and shall be exchanged as provided in
Section 1.7.
4.
1.7 Exchange of Certificates .
(a) On or prior to the Closing Date, Parent shall
select a reputable bank or trust company reasonably acceptable to
the Company to act as payment and exchange agent in the Merger (the
“ Exchange Agent ”). As promptly as practicable
after the Effective Time, Parent shall deposit with the Exchange
Agent: (i) certificates representing the shares of Parent
Common Stock issuable pursuant to Section 1.5(a)(iii); and
(ii) cash sufficient to make payments in lieu of fractional
shares in accordance with Section 1.5(c). The shares of Parent
Common Stock and cash amounts so deposited with the Exchange Agent,
together with any dividends or distributions received by the
Exchange Agent with respect to such shares of Parent Common Stock,
are referred to collectively as the “ Exchange Fund
.”
(b) As promptly as practicable after the Effective
Time, the Exchange Agent will mail to the Persons who were record
holders of Company Stock Certificates immediately prior to the
Effective Time: (i) a letter of transmittal in customary form
and containing such provisions as Parent may reasonably specify
(including a provision confirming that delivery of Company Stock
Certificates shall be effected, and risk of loss and title to
Company Stock Certificates shall pass, only upon delivery of such
Company Stock Certificates to the Exchange Agent); and
(ii) instructions for use in effecting the surrender of
Company Stock Certificates in exchange for cash and certificates
representing Parent Common Stock. Upon surrender of a Company Stock
Certificate to the Exchange Agent for exchange, together with a
duly executed letter of transmittal and such other documents as may
be reasonably required by the Exchange Agent or Parent:
(A) the holder of such Company Stock Certificate shall be
entitled to receive in exchange therefor, a certificate
representing the number of whole shares of Parent Common Stock that
such holder has the right to receive pursuant to the provisions of
Section 1.5(a)(iii)(and cash in lieu of any fractional share
of Parent Common Stock pursuant to Section 1.5(c)); and
(B) the Company Stock Certificate so surrendered shall be
canceled. Until surrendered as contemplated by this
Section 1.7(b), each Company Stock Certificate shall be
deemed, from and after the Effective Time, to represent only the
right to receive cash and shares of Parent Common Stock pursuant to
the provisions of Section 1.5(a)(iii) and cash in lieu of any
fractional share of Parent Common Stock pursuant to
Section 1.5(c). If any Company Stock Certificate shall have
been lost, stolen or destroyed, Parent may, in its discretion and
as a condition to the payment of any cash or the issuance of any
certificate representing Parent Common Stock, require the owner of
such lost, stolen or destroyed Company Stock Certificate to provide
an appropriate affidavit and to deliver a bond (in such sum as
Parent may reasonably direct) as indemnity against any claim that
may be made against the Exchange Agent, Parent or the Surviving
Corporation with respect to such Company Stock
Certificate.
(c) No dividends or other distributions declared or
made with respect to Parent Common Stock with a record date after
the Effective Time shall be paid or otherwise delivered to the
holder of any unsurrendered Company Stock Certificate with respect
to the shares of Parent Common Stock that such holder has the right
to receive in the Merger until such holder surrenders such Company
Stock Certificate in accordance with this Section 1.7 (at
which time such holder shall be entitled, subject to the effect of
applicable abandoned property, escheat or similar laws, to receive
all such dividends and distributions, without interest).
5.
(d) Any portion of the Exchange Fund that remains
undistributed to holders of Company Stock Certificates as of the
date 180 days after the date on which the Merger becomes effective
shall be delivered to Parent upon demand, and any holders of
Company Stock Certificates who have not theretofore surrendered
their Company Stock Certificates in accordance with this
Section 1.7 shall thereafter look only to Parent for
satisfaction of their claims for shares of Parent Common Stock
pursuant to the provisions of Section 1.5(a)(iii), cash in
lieu of fractional shares of Parent Common Stock pursuant to
Section 1.5(c) and any dividends or distributions with respect
to shares of Parent Common Stock.
(e) Each of the Exchange Agent, Parent and the
Surviving Corporation shall be entitled to deduct and withhold from
any consideration payable or otherwise deliverable pursuant to this
Agreement to any holder or former holder of Company Common Stock
such amounts as may be required to be deducted or withheld from
such consideration under the Code or any provision of state, local
or foreign tax law or under any other applicable Legal Requirement.
To the extent such amounts are so deducted or withheld, such
amounts shall be treated for all purposes under this Agreement as
having been paid to the Person to whom such amounts would otherwise
have been paid.
(f) Neither Parent nor the Surviving Corporation
shall be liable to any holder or former holder of Company Common
Stock or to any other Person with respect to any shares of Parent
Common Stock (or dividends or distributions with respect thereto),
or for any cash amounts, delivered to any public official pursuant
to any applicable abandoned property law, escheat law or other
similar Legal Requirement.
1.8 Tax Consequences
. For federal income tax purposes,
the Merger is intended to constitute a “reorganization”
within the meaning of Section 368 of the Code, and the parties
will report the Merger as such for federal, state and local income
tax purposes. None of the parties will knowingly take any action,
or fail to take any action, which action or failure to act would
cause the Merger to fail to qualify as a reorganization within the
meaning of Section 368 of the Code or the Treasury Regulations
promulgated thereunder. The parties to this Agreement adopt this
Agreement as a “plan of reorganization” within the
meaning of Sections 1.368-2(g) and 1.368-3(a) of the United States
Treasury Regulations.
1.9 Appraisal Rights
.
(a) Notwithstanding anything to the contrary
contained in this Agreement, any shares of Company Capital Stock
that, as of immediately prior to the Effective Time, are held by
holders who have as of such time preserved appraisal rights under
Section 262 of the DGCL with respect to such shares shall not
be converted into or represent the right to receive shares of
Parent Common Stock in accordance with Section 1.5(a)(iii), or
cash in lieu of fractional shares in accordance with
Section 1.5(c), and the holder or holders of such shares shall
be entitled only to such rights as may be granted to such holder or
holders pursuant to Section 262 of the DGCL; provided,
however, that if such appraisal rights shall not be perfected
or the holders of such shares shall otherwise lose their appraisal
rights with respect to such shares, then,
6.
as of the later of the Effective Time or the
time of the failure to perfect such status or the loss of such
rights, such shares shall automatically be converted into and shall
represent only the right to receive (upon the surrender of such
holder’s Company Stock Certificate(s) in accordance with
Section 1.7) shares of Parent Common Stock in accordance with
Section 1.5(a)(iii) and cash in lieu of fractional shares in
accordance with Section 1.5(c).
(b) The Company shall give Parent: (i) prompt
notice of any written demand received by the Company prior to the
Effective Time to require the Company to purchase shares of Company
Common Stock pursuant to Section 262 of the DGCL and of any
other demand, notice or instrument delivered to the Company prior
to the Effective Time pursuant to the DGCL; and (ii) the
opportunity to participate in all negotiations and proceedings with
respect to any such demand, notice or instrument. The Company shall
not make any payment or settlement offer prior to the Effective
Time with respect to any such demand unless Parent shall have
consented in writing to such payment or settlement
offer.
1.10 Further Action . If, at any time after
the Effective Time, any further action is determined by Parent or
the Surviving Corporation to be necessary or desirable to carry out
the purposes of this Agreement or to vest the Surviving Corporation
with full right, title and possession of and to all rights and
property of Merger Sub and the Company, the officers and directors
of the Surviving Corporation and Parent shall be fully authorized
(in the name of Merger Sub, in the name of the Company and
otherwise) to take such action.
SECTION 2. R
EPRESENTATIONS
AND W ARRANTIES OF THE C OMPANY
The Company represents and warrants
to Parent and Merger Sub as follows (it being understood that each
representation and warranty contained in this Section 2 is
subject to: (a) the exceptions and disclosures set forth in
the part or subpart of the Company Disclosure Schedule
corresponding to the particular Section or subsection in this
Section 2 in which such representation and warranty appears;
(b) any exceptions or disclosures explicitly cross-referenced
in such part or subpart of the Company Disclosure Schedule by
reference to another part or subpart of the Company Disclosure
Schedule; and (c) any exception or disclosure set forth in any
other part or subpart of the Company Disclosure Schedule to the
extent it is readily apparent from the wording of such exception or
disclosure that such exception or disclosure is intended to qualify
such representation and warranty):
2.1 Subsidiaries; Due Organization; Etc
.
(a) Part 2.1(a) of the Company Disclosure Schedule
identifies each Subsidiary of the Company and indicates its
jurisdiction of organization. Neither the Company nor any of the
Entities identified in Part 2.1(a) of the Company Disclosure
Schedule owns any capital stock of, or any equity interest of any
nature in, any other Entity, other than the Entities identified in
Part 2.1(a) of the Company Disclosure Schedule. None of the
Acquired Corporations has agreed or is obligated to make, or is
bound by any Contract under which it may become obligated to make,
any future investment in or capital contribution to any other
Entity.
(b) Each of the Acquired Corporations is a
corporation duly organized, validly existing and, in jurisdictions
that recognize the concept, is in good standing under
the
7.
laws of the jurisdiction of its incorporation
and has all necessary power and authority: (i) to conduct its
business in the manner in which its business is currently being
conducted; (ii) to own and use its assets in the manner in
which its assets are currently owned and used; and (iii) to
perform its obligations under all Contracts by which it is
bound.
(c) Each of the Acquired Corporations (in
jurisdictions that recognize the following concepts) is qualified
to do business as a foreign corporation, and is in good standing,
under the laws of all jurisdictions where the nature of its
business requires such qualification, except as would not have and
would not reasonably be expected to have or result in a Company
Material Adverse Effect.
2.2 Certificate of Incorporation
and Bylaws. The Company
has delivered to Parent accurate and complete copies of:
(a) the certificate of incorporation, bylaws and other charter
and organizational documents of each Acquired Corporation,
including all amendments thereto; (b) the stock records of
each Acquired Corporation; and (c) the minutes and other
records of the meetings and other proceedings (including any
actions taken by written consent or otherwise without a meeting) of
the stockholders of each Acquired Corporation, the board of
directors of each Acquired Corporation and all committees of the
board of directors of each Acquired Corporation. The books of
account, stock records, minute books and other records of the
Acquired Corporations are accurate, up-to-date and complete in all
material respects, and have been maintained in accordance with
prudent business practices.
2.3 Capitalization, Etc .
(a) The authorized capital stock of the Company
consists of 26,000,000 shares of Company Common Stock, of which
5,713,818 shares have been issued and are outstanding as of the
date of this Agreement, 9,222,257 shares of Series A Preferred
Stock, all of which have been issued and are outstanding as of the
date of this Agreement, and 3,720,692 shares of Series B-1
Preferred Stock, of which 3,688,902 shares have been issued and are
outstanding as of the date of this Agreement and 2,791,269 shares
of Series B-2 Preferred Stock, of which 2,766,677 have been issued
and are outstanding as of the date of this Agreement. Except as set
forth in Part 2.3(a)(i) of the Company Disclosure Schedule, the
Company does not hold any shares of its capital stock in its
treasury. All of the outstanding shares of Company Capital Stock
have been duly authorized and validly issued, and are fully paid
and nonassessable. Except as set forth in Part 2.3(a)(ii) of the
Company Disclosure Schedule: (i) none of the outstanding
shares of Company Capital Stock is entitled or subject to any
preemptive right, right of participation, right of maintenance or
any similar right; (ii) none of the outstanding shares of
Company Capital Stock is subject to any right of first refusal or
similar right in favor of the Company or any other Person; and
(iii) there is no Company Contract relating to the voting or
registration of, or restricting any Person from purchasing,
selling, pledging or otherwise disposing of (or granting any option
or similar right with respect to), any shares of Company Capital
Stock. None of the Acquired Corporations is under any obligation,
or is bound by any Contract pursuant to which it may become
obligated, to repurchase, redeem or otherwise acquire any
outstanding shares of Company Capital Stock or any other
securities. Part 2.3(a)(iii) of the Company Disclosure Schedule
provides an accurate and complete description of the terms of each
repurchase option which is held by the Company and to which any of
the shares of Company Capital Stock is subject. Each share of
Company Preferred Stock is convertible into one share of Company
Common Stock.
8.
(b) As of the date of this Agreement, 3,385,351
shares of Company Common Stock are subject to issuance pursuant to
outstanding Company Options. Part 2.3(b)(i) of the Company
Disclosure Schedule sets forth accurate and complete information
with respect to the holder, the vesting, the exercise price, the
expiration date, the shares underlying, the applicable Company
Option Plan, and the tax status of each Company Option outstanding
as of the date of this Agreement. No Company Option is held by a
Person residing or domiciled outside of the United States. All
outstanding Company Options were granted pursuant to the terms of
one of the Company Option Plans. The Company has delivered to
Parent accurate and complete copies of all stock option plans
pursuant to which any of the Acquired Corporations has ever granted
stock options, and the forms of all stock option agreements
evidencing such options. The Company Option Plans are binding upon
and enforceable by the Company against all holders of Company
Options, subject to (i) laws of general application relating
to bankruptcy, insolvency, reorganization, moratorium and the
enforcement of creditors’ rights generally, and
(ii) rules of law governing specific performance, injunctive
relief and other equitable remedies. As of the date of this
Agreement, 56,382 shares of Company Preferred Stock are subject to
issuance pursuant to outstanding warrants (“ Company
Warrants ”). Part 2.3(b)(ii) of the Company Disclosure
Schedule sets forth accurate and complete information with respect
to the holder, the vesting, the exercise price, the expiration date
and the shares underlying each Company Warrant outstanding as of
the date of this Agreement. The Company has delivered to Parent
accurate and complete copies of all Company Warrants.
(c) Except as set forth in Part 2.3(b) of the
Company Disclosure Schedule, there is no: (i) outstanding
subscription, option, call, warrant or right (whether or not
currently exercisable) to acquire any shares of the capital stock
or other securities of any of the Acquired Corporations;
(ii) outstanding security, instrument or obligation that is or
may become convertible into or exchangeable for any shares of the
capital stock or other securities of any of the Acquired
Corporations; (iii) Contract under which any of the Acquired
Corporations is or may become obligated to sell or otherwise issue
any shares of its capital stock or any other securities; or
(iv) condition or circumstance that may give rise to or
provide a basis for the assertion of a claim by any Person to the
effect that such Person is entitled to acquire or receive
(A) any shares of capital stock or other securities of any of
the Acquired Corporations, or (B) any portion of any Merger
Consideration or other consideration payable in connection with the
Merger (other than in respect of outstanding shares of Company
Capital Stock as set forth in Section 2.3(a)).
(d) All outstanding shares of capital stock, and all
options, warrants and other securities of the Acquired Corporations
have been issued and granted in compliance with (i) all
applicable securities laws and other applicable Legal Requirements,
and (ii) all requirements set forth in applicable
Contracts.
(e) All of the outstanding shares of capital stock
of each of the Company’s Subsidiaries have been duly
authorized and validly issued, are fully paid and nonassessable and
free of preemptive rights, with no personal liability attaching to
the ownership thereof, and are owned beneficially and of record by
the Company, free and clear of any Encumbrances.
9.
(f) Except as set forth in Part 2.3(f) of the
Company Disclosure Schedule, none of the Acquired Corporations has
ever repurchased, redeemed or otherwise reacquired any shares of
Company Capital Stock or other securities of any Acquired
Corporation, other than Company Options forfeited by Company
Employees in connection with the termination of a Company
Employee’s employment with an Acquired Corporation. All
securities so reacquired by the Company or any other Acquired
Corporation were reacquired in compliance with (i) all
applicable Legal Requirements, and (ii) all requirements set
forth in applicable restricted stock purchase agreements and other
applicable Contracts.
2.4 Financial Statements; Financial Controls
.
(a) The Company has delivered to Parent the
following financial statements and notes (collectively, the “
Company Financial Statements ”): (i) the audited
consolidated balance sheets of the Company and its consolidated
Subsidiaries as of December 31, 2005, 2006 and 2007 and the
related audited consolidated statements of operations, statements
of stockholders’ equity and statements of cash flows of the
Company and its consolidated Subsidiaries for the years then ended,
together with the independent auditor’s report therefor and
notes thereto; and (ii) the unaudited consolidated balance
sheet of the Company and its consolidated Subsidiaries as of
June 30, 2008 (the “ Most Recent Balance Sheet
”), and the related unaudited statement of income, statement
of stockholders’ equity and statement of cash flows of the
Company and its consolidated Subsidiaries for the six months then
ended. The Acquired Corporations’ Net Cash as of
August 31, 2008 was $ 4,180,069.
(b) The Company Financial Statements are accurate
and complete in all material respects and fairly present the
financial position of the Company and its consolidated Subsidiaries
as of the respective dates thereof and the results of operations
and cash flows of the Company and its consolidated Subsidiaries for
the periods covered thereby. The Company Financial Statements have
been prepared in accordance with GAAP applied on a consistent basis
throughout the periods covered (except that the financial
statements referred to in Section 2.4(a)(ii) do not contain
footnotes and are subject to normal and recurring year end
adjustments, which will not, individually or in the aggregate, be
material in magnitude).
(c) Each of the Acquired Corporations maintains
accurate books and records reflecting its assets and liabilities
and maintains proper and adequate internal accounting controls
which provide assurance that: (i) transactions are executed
with management’s authorization; (ii) transactions are
recorded as necessary to permit preparation of the consolidated
financial statements of the Company and its consolidated
Subsidiaries and to maintain accountability for the assets of the
Acquired Corporations; (iii) access to the assets of the
Acquired Corporations is permitted only in accordance with
management’s authorization; (iv) the reporting of the
assets of the Acquired Corporations is compared with existing
assets at regular intervals; and (v) accounts, notes and other
receivables are recorded accurately, and proper and adequate
procedures are implemented to effect the collection thereof on a
current and timely basis.
10.
(d) The Company and each of the parties (other than
Parent) to that convertible note purchase agreement dated of even
date herewith and provided to Parent (the “ Note Purchase
Agreement ”) have duly authorized, executed and delivered
the Note Purchase Agreement. The Note Purchase Agreement
constitutes the legal, valid and binding obligation of the Company
and each of the other parties to the Note Purchase Agreement (other
than Parent), enforceable against such parties in accordance with
its terms, subject to: (i) laws of general application
relating to bankruptcy, insolvency and the relief of debtors; and
(ii) rules of law governing specific performance, injunctive
relief and other equitable remedies. The Company has exercised all
of its rights under the Note Purchase Agreement to obligate the
parties (other than the Company and Parent) to purchase not less
than $8,750,000 in principal amount of convertible notes pursuant
to the Note Purchase Agreement (for consideration equal to the
principal amount of such notes) subject solely to the closing
conditions set forth in the Note Purchase Agreement. The board of
directors of the Company (at a meeting duly called and held) has
unanimously approved the “Charter Amendment” as such
term is defined in the Note Purchase Agreement (the “
Company NPA Charter Amendment ”), holders of a
requisite number of shares of the Company’s capital stock
have approved the Company NPA Charter Amendment such that it has
been adopted and approved, all in accordance with the DGCL, and the
officers of the Company have been authorized and instructed to file
the Company NPA Charter Amendment with the Secretary of State of
the State of Delaware.
2.5 Absence of Changes. Except as set forth
in Part 2.5 of the Company Disclosure Schedule, between
December 31, 2007 and the date of this Agreement:
(a) there has not been any Company Material Adverse Effect,
and no event has occurred or circumstance has arisen that, in
combination with any other events or circumstances, would
reasonably be expected to have or result in a Company Material
Adverse Effect; (b) there has not been any material loss,
damage or destruction to, or any material interruption in the use
of, any of the assets of any of the Acquired Corporations (whether
or not covered by insurance); (c) none of the Acquired
Corporations has received any inquiry, proposal or offer relating
to a possible Acquisition Transaction; (d) none of the
Acquired Corporations has made any capital expenditure which, when
added to all other capital expenditures made on behalf of the
Acquired Corporations since December 31, 2007, exceeds
$100,000 in the aggregate; (e) none of the Acquired
Corporations has written off as uncollectible, or established any
extraordinary reserve with respect to, any account receivable or
other indebtedness; (f) none of the Acquired Corporations has
entered into any material transaction or taken any other material
action outside the ordinary course of business or inconsistent with
past practices; (g) none of the Acquired Corporations has
taken any action of the type referred to in Section 4.2(b);
and (h) none of the Acquired Corporations has agreed or
committed to take any of the actions referred to in clauses
“(c)” through “(g)” of this
sentence.
2.6 Title to Assets. The Acquired
Corporations own, and have good, valid and marketable title to, all
assets purported to be owned by them, including: (a) all
assets reflected on the Most Recent Balance Sheet (except for
inventory sold or otherwise disposed of in the ordinary course of
business since the date of the Most Recent Balance Sheet); and
(b) all other assets reflected in the books and records of the
Acquired Corporations as being owned by the Acquired Corporations.
All of said assets are owned by the Acquired Corporations free and
clear of any Encumbrances, except for (i) any lien for current
taxes not yet due and payable, (ii) minor liens that have
arisen in the ordinary course of business and that do not (in any
case or in
11.
the aggregate) materially detract from the value
of the assets subject thereto or materially impair the operations
of any Acquired Corporation, and (iii) liens described in Part
2.6 of the Company Disclosure Schedule. The Acquired Corporations
are the lessees of, and hold valid leasehold interests in, all
assets purported to have been leased by them, including:
(A) all assets reflected as leased on the Most Recent Balance
Sheet; and (B) all other assets reflected in the books and
records of the Acquired Corporations as being leased to the
Acquired Corporations, and the Acquired Corporations enjoy
undisturbed possession of such leased assets.
2.7 Receivables;
Customers.
(a) Part 2.7(a) of the Company Disclosure Schedule
contains an accurate and complete list as of the date of this
Agreement of all outstanding loans and advances made by any of the
Acquired Corporations to any Company Associate, other than routine
travel advances made to directors or officers or other employees in
the ordinary course of business.
(b) Part 2.7(b)(i) of the Company Disclosure
Schedule accurately identifies, and provides an accurate and
complete breakdown of the revenues received from, each customer or
other Person that accounted for revenues of at least $100,000 in
the fiscal year ended December 31, 2006 or the fiscal year
ended December 31, 2007. The Company has not received any
notice or other communication, and has not received any other
information, indicating that any customer or other Person
identified or required to be identified in Part 2.7(b) of the
Company Disclosure Schedule may cease dealing with any of the
Acquired Corporations. Part 2.7(b)(ii) of the Company Disclosure
Schedule identifies, as of the date of this Agreement, each Person
that, pursuant to any Company Contract, is required to pay to an
Acquired Corporation after the date of this Agreement $100,000 or
more in cash if any payments under such Contract have not been
recognized as revenue by any Acquired Corporation on or prior to
the date of this Agreement. The Company has delivered to Parent
information setting forth: (A) the amount of cash that the
Acquired Corporations expect to receive from each Person referred
to in the immediately preceding sentence; and (B) the fiscal
quarter in which the Acquired Corporations expect to receive such
cash (it being understood that no representation or warranty is
being made pursuant to this sentence as to whether or when such
amounts will actually be received by the Acquired
Corporations).
2.8 Equipment; Leasehold. All material items
of equipment and other tangible assets owned by or leased to the
Acquired Corporations are adequate for the uses to which they are
being put, are in good condition and repair (ordinary wear and tear
excepted) and are adequate for the conduct of the business of the
Acquired Corporations in the manner in which such business is
currently being conducted. No Acquired Corporation owns any real
property or any interest in real property, except for the
leaseholds created under the real property leases identified in
Part 2.8 of the Company Disclosure Schedule.
2.9 Intellectual Property .
(a) Part 2.9(a) of the Company Disclosure Schedule
sets forth a complete and accurate list as of the date of this
Agreement of: (i) all Registered Intellectual Property (as
defined below) in which any of the Acquired Corporations has any
ownership interest (collectively, the “ Owned Intellectual
Property ”); and (ii) all IP Contracts (as
defined
12.
below) relating to the Company Intellectual
Property; provided that such list need not include
“shrink-wrap” and similar licenses for off-the-shelf
retail-available software used solely on the computers of the
Company or its Subsidiaries (collectively, “ Shrink Wrap
Licenses ”). For purposes of this Agreement the terms
(A) “ Intellectual Property ” shall mean
any and all of the following, and rights in, arising out of, or
associated therewith: U.S. and non-U.S. (i) non-expired
patents, utility models, supplementary protection certificates and
applications therefor (including provisional applications,
invention disclosures, certificates of invention and applications
for certificates of invention) and divisionals, continuations,
continuations-in-part, patents of addition, reissues, renewals,
extensions, re-examinations, and equivalents thereof throughout the
world (“ Patents ”), (ii) trade secrets,
know-how, proprietary information, inventions, discoveries,
improvements, technology, technical data and research and
development, whether patentable or not (collectively, “
Trade Secrets ”), (iii) trademarks, service
marks, trade dress, trade names and Internet domain names and
registrations and applications therefor, and equivalents thereof
throughout the world, (iv) copyrights, mask works,
registrations and applications therefor, and equivalents thereof
throughout the world, (v) computer software and firmware,
including all source code, object code, specifications, databases,
designs and documentation (collectively, “ Software
”) and (vi) other intellectual property, industrial
property and proprietary rights and all applications, registrations
and grants related thereto; (B) “ IP Contracts
” shall mean, collectively, any and all agreements pursuant
to which rights to any material Intellectual Property are in any
manner transferred, conveyed, licensed, granted, restricted or
waived; (C) “ Registered Intellectual Property
” shall mean all registered copyrights and trademarks and all
issued Patents; and (D) “ Company Intellectual
Property ” shall mean the Owned Intellectual Property and
all other Intellectual Property that is used by or licensed to the
Acquired Corporations.
(b) An Acquired Corporation is the owner or joint
owner of each item of Intellectual Property in which it has an
ownership interest (collectively, the “ Company Owned
Intellectual Property ”), and has the right to use all
other Company Intellectual Property, in each case free and clear of
all Encumbrances. An Acquired Corporation is listed in the records
of the appropriate U.S. and/or non-U.S. Governmental Body as the
sole and exclusive owner of record for each registration, grant and
application included in the Company Owned Intellectual Property,
except as otherwise disclosed in Part 2.9(b) of the Company
Disclosure Schedule.
(c) To the Company’s Knowledge, the Company
Intellectual Property and all of the Acquired Corporations’
rights therein, is and are valid and enforceable. To the
Company’s Knowledge, there are no facts, proceedings, claims
or challenges that cause or would cause any Company Intellectual
Property to be invalid or unenforceable, or challenging the
Acquired Corporations’ rights in any Company Intellectual
Property, and no Acquired Corporation has received any notice from
any Person bringing or threatening to bring such proceedings,
claims or challenges. No act has been done or omitted to be done by
the Acquired Corporations, which has, had or could have the effect
of impairing or dedicating to the public, or entitling any Person
to cancel, forfeit, modify or consider abandoned, any Company Owned
Intellectual Property, or, except with respect to IP Contracts
listed in Part 2.9(a) of the Company Disclosure Schedule, give any
Person any rights with respect thereto. All necessary registration,
maintenance and renewal fees in respect of the Company Owned
Intellectual Property have been paid and all necessary documents
and certificates have been filed with the relevant
13.
Governmental Authorities for the purpose of
maintaining such Company Owned Intellectual Property. The Acquired
Corporations have not divulged, furnished to or made accessible any
of their Trade Secrets to any Person who is not subject to an
enforceable written agreement to maintain the confidentiality of
such Trade Secrets, and the Acquired Corporations otherwise take
and have taken reasonable measures to maintain the confidentiality
of their Trade Secrets.
(d) To the Company’s Knowledge, none of the
Acquired Corporations or any of their respective current or
contemplated activities, or products misappropriates, violates or
otherwise conflicts with, or has infringed, misappropriated or
violated, or will infringe, misappropriate or violate any
Intellectual Property of any Person, and no Acquired Corporation
has received any notice nor are any of them subject to any actual
or threatened proceedings claiming or alleging any of the
foregoing. No proceedings or claims in which an Acquired
Corporation alleges that any Person is infringing, misappropriating
or otherwise violating any Owned Intellectual Property are pending,
and none have been served by, instituted or asserted by the
Acquired Corporations, nor are the Acquired Corporations aware of
any such infringement, misappropriation or violation. To the
Company’s Knowledge, there are no breaches or defaults of, or
any disputes or threatened disputes concerning, any of the IP
Contracts.
(e) The consummation of the transactions
contemplated by this Agreement will not (i) result in the loss
of, or otherwise adversely affect, any material rights of the
Acquired Corporations in any Company Intellectual Property, or
(ii) grant or require any Acquired Corporation to grant to any
Person any rights with respect to any Company Intellectual
Property, (iii) subject the Acquired Corporations to any
increase in royalties or other payments in respect of any Company
Intellectual Property, (iv) diminish any royalties or other
payments the Company or its Subsidiaries would otherwise be
entitled to in respect of any Company Intellectual Property, or
(v) result in the material breach or, by the terms of such
contract, termination of any Company Contract.
2.10 Contracts .
(a) Part 2.10 of the Company Disclosure Schedule
identifies each Company Contract that constitutes a Company
Material Contract. For purposes of this Agreement, each of the
following shall be deemed to constitute a “ Company
Material Contract ”:
(i) any Company Contract: (A) constituting a
Company Employee Agreement; (B) pursuant to which any of the
Acquired Corporations or Company Affiliates is or may become
obligated to make any severance, termination, deferred compensation
or similar payment, or provide any post-termination employee
benefits (whether cash, equity or otherwise), to any Company
Associate or any spouse, heir or Representative of any Company
Associate; (C) pursuant to which any of the Acquired
Corporations or Company Affiliates is or may become obligated to
pay any bonus (including any retention bonus or success bonus) or
similar payment (other than payments constituting base salary or
commissions paid in the ordinary course of business) in excess of
$100,000 to any Company Associate; (D) pursuant to which any
of the Acquired Corporations or Company Affiliates is or may become
obligated to accelerate the vesting, exercisability or issuance of,
or otherwise modify, any stock option, restricted stock, stock
appreciation right or other equity interest in any of the
Acquired
14.
Corporations; (E) pursuant to which any of
the Acquired Corporations or Company Affiliates is or may become
obligated to pay or accelerate the vesting or payment of any bonus,
tax reimbursement or other payment (whether cash, equity, or
otherwise) to any Company Associate as a result of the Merger or
any of the other Contemplated Transactions, alone or in combination
with any other event; or (F) with any works council, labor
union or similar organization or body;
(ii) any Company Contract identified or required to
be identified in Part 2.9 of the Company Disclosure
Schedule;
(iii) any Company Contract with any distributor and
any Company Contract with any other reseller or sales
representative that includes any provision with respect to
exclusivity;
(iv) any Company Contract with any manufacturer,
vendor, foundry, or other supplier, including any Company Contract
for the performance of services by a third party relating to any
Company Intellectual Property or Company Product;
(v) any Company Contract that provides for:
(A) reimbursement of any Company Associate for, or advancement
to any Company Associate of, legal fees or other expenses
associated with any Legal Proceeding or the defense thereof; or
(B) indemnification of any Company Associate;
(vi) any Company Contract imposing any restriction on
the right or ability of any Acquired Corporation: (A) to
compete with any other Person; (B) to acquire any product or
other asset or any services from any other Person; (C) to
solicit, hire or retain any Person as a director, an officer or
other employee, a consultant or an independent contractor;
(D) to develop, sell, supply, distribute, offer, support or
service any product or any technology or other asset to or for any
other Person; (E) to perform services for any other Person; or
(F) to transact business with any other Person;
(vii) any Company Contract incorporating or relating
to any guaranty, any warranty, any sharing of liabilities or any
indemnity (including any indemnity with respect to Intellectual
Property) or similar obligation;
(viii) any Company Contract relating to any currency
hedging;
(ix) any Company Contract requiring that any of the
Acquired Corporations give any notice or provide any information to
any Person prior to considering or accepting any Acquisition
Proposal or similar proposal, or prior to entering into any
discussions, agreement, arrangement or understanding relating to
any Acquisition Transaction or similar transaction;
(x) any Company Contract relating to the ownership,
lease or sublease of any property that is leased to or controlled,
owned or used by any of the Acquired Corporations;
(xi) any Company Contract constituting or relating to
a Government Contract or Government Bid that contemplates or
involves the payment or delivery
15.
of cash or other consideration in an amount or
having a value in excess of $100,000 in the aggregate, or
contemplates or involves the performance of services having a value
in excess of $100,000 in the aggregate;
(xii) any Company Contract that contemplates or
involves the payment or delivery of cash or other consideration in
an amount or having a value in excess of $100,000 in the aggregate,
or contemplates or involves the performance of services having a
value in excess of $100,000 in the aggregate;
(xiii) any Company Contract that has a term of more
than one year and that may not be terminated by an Acquired
Corporation (without penalty in excess of $100,000) within 60 days
after the delivery of a termination notice by such Acquired
Corporation (other than confidentiality or nondisclosure agreements
entered into by any Acquired Corporation in the ordinary course of
business);
(xiv) any Company Contract that would reasonably be
expected to have a material effect on the ability of the Company to
perform any of its obligations under this Agreement, or to
consummate any of the Contemplated Transactions;
(xv) any Company Contract that provides for:
(A) any right of first refusal, right of first negotiation,
right of first notification or similar right with respect to any
securities or assets of any Acquired Corporation; or (B) any
“no shop” provision or similar exclusivity provision
with respect to any securities or assets of any Acquired
Corporation; and
(xvi) any other Company Contract that is material to
any Acquired Corporation.
The Company has delivered to Parent
an accurate and complete copy of each Company Contract that
constitutes a Company Material Contract.
(b) Each Company Contract is valid and in full force
and effect, and is enforceable in accordance with its terms,
subject to: (i) laws of general application relating to
bankruptcy, insolvency and the relief of debtors; and
(ii) rules of law governing specific performance, injunctive
relief and other equitable remedies.
(c) Except as set forth in Part 2.10(c) of the
Company Disclosure Schedule: (i) none of the Acquired
Corporations has violated or breached in any material respect, or
committed any default in any material respect under, any Company
Contract; (ii) to the Knowledge of the Company, no other
Person has violated or breached in any material respect, or
committed any default in any material respect under, any Company
Contract; (iii) to the Knowledge of the Company, no event has
occurred, and no circumstance or condition exists, that (with or
without notice or lapse of time) would reasonably be expected to:
(A) result in a violation or breach in any material respect of
any of the provisions of any Company Contract; (B) give any
Person the right to declare a default in any material respect under
any Company Contract; (C) give any Person the right to receive
or require a rebate, chargeback, penalty or change in delivery
schedule under any Company Contract; (D) give any Person the
right to accelerate the maturity or performance of any Company
Contract that constitutes a Company Material Contract;
(E) result in the disclosure, release or delivery of any
Company Source Code;
16.
or (F) give any Person the right to cancel,
terminate or modify any Company Contract that constitutes a Company
Material Contract; and (iv) since December 31, 2004, none
of the Acquired Corporations has received any notice or other
communication regarding any actual or possible violation or breach
of, or default under, any Company Material Contract.
2.11 Liabilities
. None of the Acquired Corporations
has any accrued, contingent or other liabilities required by GAAP
to be set forth on a consolidated balance sheet of the Company or
in the notes thereto, except for: (a) liabilities identified
as such, or specifically reserved against, in the Most Recent
Balance Sheet; (b) normal and recurring current liabilities
that have been incurred by the Acquired Corporations since the date
of the Most Recent Balance Sheet in the ordinary course of business
and consistent with past practices; (c) liabilities for
performance of obligations of the Acquired Corporations pursuant to
the express terms of Company Contracts; and (d) liabilities
described in Part 2.11 of the Company Disclosure
Schedule.
2.12 Compliance with Legal
Requirements .
(a) The Acquired Corporations and Persons acting in
concert with or on behalf of the Acquired Corporations are not, nor
has any of them since December 31, 2004 been, in violation of
any Legal Requirement applicable to the Acquired Corporations or by
which any of their respective properties are bound or any
regulation issued under any of the foregoing or has been notified
in writing by any Governmental Body of any violation, or any
investigation with respect to any such Legal Requirement, including
Legal Requirements enforced by the United States Food and Drug
Administration (the “ FDA ”), the European
Medicines Agency (“ EMEA ”) and other comparable
Governmental Authorities (collectively, “ Drug Law
”), except for any such violation that would not, or would
not reasonably be expected to, individually or in the aggregate,
have a Company Material Adverse Effect.
(b) The Acquired Corporations have all material
registrations, applications, licenses, requests for approvals,
exemptions, permits and other regulatory authorizations (“
Authorizations ”) from Governmental Authorities
required to conduct their respective businesses as now being
conducted. Such Authorizations are valid and in full force and
effect, and the Acquired Corporations and Persons acting in concert
with and on behalf of the Acquired Corporations are in compliance
in all material respects with all such Authorizations. The Company
has provided to Parent all material Authorizations from the FDA and
the EMEA.
(c) To the Knowledge of the Company, the Acquired
Corporations and Persons acting in concert with and on behalf of
the Company:
(i) have not used in any capacity the services of
any individual or entity debarred, excluded, or disqualified under
21 U.S.C. Section 335a, 42 U.S.C. Section 1320a-7, 21
C.F.R. Section 312.70, or any similar laws, rules or
regulations; and
(ii) have not been convicted of any crime or engaged
in any conduct that has resulted, or would reasonably be expected
to result, in debarment, exclusion, or disqualification under 21
U.S.C. Section 335a, 42 U.S.C. Section 1320a-7, 21 C.F.R.
Section 312.70, or any similar laws, rules
regulations.
17.
(d) None of the Acquired Corporations, and (to the
Knowledge of the Company) no Representative of any of the Acquired
Corporations with respect to any matter relating to any of the
Acquired Corporations, has: (i) used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses
relating to political activity; (ii) made any unlawful payment
to foreign or domestic government officials or employees or to
foreign or domestic political parties or campaigns or violated any
provision of the Foreign Corrupt Practices Act of 1977, as amended;
or (iii) made any other unlawful payment.
(e) No product or product candidate manufactured,
tested, distributed, held or marketed by or on behalf of any of the
Acquired Corporations has been recalled, withdrawn, suspended or
discontinued (whether voluntarily or otherwise) since
December 31, 2004. At no time since December 31, 2004,
has any of the Acquired Corporations received notice that any
Governmental Body or institutional review board or comparable body
has commenced, or threatened to initiate, any proceeding seeking
the recall, market withdrawal, suspension or withdrawal of
approval, or seizure of any such product or product candidate; the
imposition of material sales, marketing or production restriction
on any product or product candidate; or the suspension, termination
or other restriction of preclinical or clinical research by or on
behalf of any of the Acquired Corporations, including any action
regarding any investigator participating in any such research, nor
is any such proceeding pending. The Company has, prior to the
execution of this Agreement, provided to Parent all information
about serious adverse drug experiences since December 31, 2004
obtained or otherwise received by any of the Acquired Corporations
from any source, in the United States or outside the United States,
including information derived from clinical investigations prior to
any market authorization approvals, commercial marketing
experience, postmarketing clinical investigations, postmarketing
epidemiological/surveillance studies or registries, reports in the
scientific literature, and unpublished scientific papers relating
to any product or product candidate manufactured, tested,
distributed, held or marketed by any of the Acquired Corporations
or any of their licensors or licensees in the possession of any of
the Acquired Corporations (or to which any of them has access),
except for any adverse drug experiences that would not, or would
not reasonably be expected to, individually or in the aggregate,
have a Company Material Adverse Effect.
(f) None of the Acquired Corporations, or Persons
acting in concert with or on behalf of the Acquired Corporations,
or any officers, employees or agents of the same has with respect
to any product that is manufactured, tested, distributed, held or
marketed by or on behalf of any of the Acquired Corporations made
an untrue statement of a material fact or fraudulent statement to
the FDA, the EMEA or any other Governmental Body, failed to
disclose a material fact required to be disclosed to the FDA, the
EMEA or any other Governmental Body, or committed an act, made a
statement, or failed to make a statement that, at the time such
disclosure was made, would reasonably be expected to provide a
basis for the FDA to invoke its policy respecting “Fraud,
Untrue Statements of Material Facts, Bribery, and Illegal
Gratuities” set forth in 56 Fed. Reg. 46191 (September 10,
1991) or for the EMEA or any other Governmental Body to invoke any
similar policy.
18.
(g) All pre-clinical and clinical studies relating
to product or product candidates, conducted by or on behalf of the
Acquired Corporations have been, or are being, conducted in
compliance with the applicable requirements of the FDA’s Good
Laboratory Practice and Good Clinical Practice requirements,
including regulations under 21 C.F.R. Parts 50, 54, 56, 58, 312 and
applicable guidance documents, as amended from time to time, the
Animal Welfare Act, and all applicable similar requirements in
other jurisdictions, and all requirements relating to protection of
human subjects.
(h) The Acquired Corporations has filed with the
FDA, any other Governmental Authority, and any institutional review
board or comparable body, all required notices, supplemental
applications, and annual or other reports, including adverse
experience reports, with respect to each investigational new drug
application or any comparable foreign regulatory application,
related to the manufacture, testing, study, or sale of any product
or product candidate, as applicable, except as would not reasonably
be expected to have a Company Material Adverse Effect.
2.13 Tax Matters
.
(a) Each of the Tax Returns required to be filed by
or on behalf of the respective Acquired Corporations with any
Governmental Body with respect to any taxable period ending on or
before the Closing Date (the “ Company Returns
”): (i) has been or will be filed on or before the
applicable due date (including any extensions of such due date);
and (ii) has been, or will be when filed, prepared in all
material respects in compliance with all applicable Legal
Requirements. All Taxes of all Acquired Corporations, whether or
not shown on the Company Returns, due on or before the Closing
Date, have been or will be paid on or before the Closing
Date.
(b) The Most Recent Balance Sheet fully accrues all
actual and contingent liabilities for Taxes with respect to all
periods through the date of this Agreement in accordance with GAAP,
except for liabilities for Taxes incurred since the date of the
Most Recent Balance Sheet in the operation of the business of the
Acquired Corporations. The Company will establish, prior to the
Closing Date, in the ordinary course of business and consistent
with its past practices, reserves adequate for the payment of all
Taxes for the period from the date of the Most Recent Balance Sheet
through the Closing Date.
(c) No Acquired Corporation and no Company Return is
currently being (or since December 31, 2004 has been) audited
by any Governmental Body. No extension or waiver of the limitation
period applicable to any of the Company Returns has been granted
(by the Company or any other Person), and no such extension or
waiver has been requested from any Acquired Corporation.
(d) No claim or Legal Proceeding is pending or, to
the Knowledge of the Company, has been threatened against or with
respect to any Acquired Corporation in respect of any material Tax.
There are no unsatisfied liabilities for material Taxes (including
liabilities for interest, additions to tax and penalties thereon
and related expenses) with respect to any notice of deficiency or
similar document received by any Acquired Corporation with respect
to any material Tax (other than liabilities for Taxes asserted
under any such notice of deficiency or
19.
similar document which are being contested in
good faith by the Acquired Corporations and with respect to which
adequate reserves for payment have been established on the Most
Recent Balance Sheet). There are no liens for material Taxes upon
any of the assets of any Acquired Corporation except liens for
current Taxes not yet due and payable. None of the Acquired
Corporations has been, and none of the Acquired Corporations will
be, required to include any adjustment in taxable income for any
tax period (or portion thereof) pursuant to Section 481 or
263A of the Code (or any comparable provision of state or foreign
Tax laws) as a result of transactions or events occurring, or
accounting methods employed, prior to the Closing.
(e) No claim has ever been received by an Acquired
Corporation from any Governmental Body in a jurisdiction where an
Acquired Corporation does not file a Tax Return that an Acquired
Corporation is or may be subject to taxation by that jurisdiction
which has resulted or would reasonably be expected to result in an
obligation by an Acquired Corporation to pay material
Taxes.
(f) There are no Company Contracts relating to
allocating or sharing of Taxes. None of the Acquired Corporations
is liable for Taxes of any other Person, or is currently under any
contractual obligation to indemnify any Person with respect to any
amounts of such Person’s Taxes nor is there any Company
Contract providing for payments by an Acquired Corporation with
respect to any amount of Taxes of any other Person. For the
purposes of this Section 2.13(f), the following Company
Contracts shall be disregarded: (i) commercially reasonable
Company Contracts providing for the allocation or payment of real
property Taxes attributable to real property leased or occupied by
any Acquired Corporation and (ii) commercially reasonable
Company Contracts for the allocation or payment of personal
property Taxes, sales or use Taxes or value added Taxes with
respect to personal property leased, used, owned or sold in the
ordinary course of business.
(g) No Acquired Corporation has constituted either a
“distributing corporation” or a “controlled
corporation” within the meaning of Section 355(a)(1)(A)
of the Code. No Acquired Corporation is or has been a “United
States real property holding corporation” within the meaning
of Section 897(c)(2) of the Code.
(h) No Acquired Corporation has been a member of an
“affiliated group of corporations” within the meaning
of Section 1504 of the Code or within the meaning of any
similar Legal Requirement to which an Acquired Corporation may be
subject, other than the affiliated group of which the Company is
the common parent.
(i) The Company has delivered to Parent accurate and
complete copies of all Tax Returns of the Acquired Corporations for
all Tax years that remain open or are otherwise subject to audit,
and all other material Tax Returns of the Acquired Corporations
filed since December 31, 2001.
(j) No Acquired Corporation has taken any position
on its federal income Tax Returns (whether or not such position has
been disclosed on such federal income Tax Returns) that would
reasonably be expected to give rise to a material understatement
penalty within the meaning of Section 6662 of the Code or any
similar Legal Requirement.
20.
(k) No Acquired Corporation has participated in, or
is currently participating in, a “Listed Transaction”
or a “Reportable Transaction” within the meaning of
Treasury Regulation Section 1.6011-4(b) or similar transaction
under any corresponding or similar Legal Requirement.
2.14 Employee and Labor Matters; Benefit Plans
.
(a) Except as set forth in Part 2.14(a) of the
Company Disclosure Schedule, none of the Acquired Corporations is a
party to or bound by, and none of the Acquired Corporations has
ever been a party to or bound by, any union contract, collective
bargaining agreement or similar Contract.
(b) None of the Acquired Corporations is or has ever
been engaged, in any unfair labor practice of any nature. There has
never been any slowdown, work stoppage, labor dispute or union
organizing activity, or any similar activity or dispute, affecting
any of the Acquired Corporations or any of their employees. There
is not now pending, and no Person has threatened to commence, any
such slowdown, work stoppage, labor dispute or union organizing
activity or any similar activity or dispute. No event has occurred,
and no condition or circumstance exists, that might directly or
indirectly give rise to or provide a basis for the commencement of
any such slowdown, work stoppage, labor dispute or union organizing
activity or any similar activity or dispute. There are no actions,
suits, claims, labor disputes or grievances pending or, to the
Knowledge of the Company, threatened or reasonably anticipated
relating to any labor, safety or discrimination matters involving
any Company Associate, including charges of unfair labor practices
or discrimination complaints.
(c) Part 2.14(c) of the Company Disclosure Schedule
contains an accurate and complete list as of the date hereof of
each Company Employee Plan and each Company Employee Agreement.
None of the Acquired Corporations intends or has agreed or
committed to (i) establish or enter into any new Company
Employee Plan or Company Employee Agreement, or (ii) modify or
terminate any Company Employee Plan or Company Employee Agreement
(except to conform any such Company Employee Plan or Company
Employee Agreement to the requirements of any applicable Legal
Requirements, in each case as previously disclosed to Parent in
writing).
(d) The Company has delivered to Parent accurate and
complete copies of: (i) all documents embodying or setting
forth the terms of each Company Employee Plan and each Company
Employee Agreement, including all amendments thereto and all
related trust documents; (ii) the three most recent annual
reports (Form Series 5500 and all schedules and financial
statements attached thereto), if any, required under ERISA, the
Code or any other applicable Legal Requirement in connection with
each Company Employee Plan; (iii) for each Company Employee
Plan that is subject to the minimum funding standards of
Section 302 of ERISA, the most recent annual and periodic
accounting of Company Employee Plan assets; (iv) the most
recent summary plan description together with the summaries of
material modifications thereto, if any, required under ERISA with
respect to each Company Employee Plan; (v) all material
written Contracts relating to each Company Employee Plan, including
administrative service agreements and group insurance contracts;
(vi) all written materials provided to any Company Associate
relating to any Company Employee Plan and any proposed
Company
21.
Employee Plan, in each case, relating to any
amendments, terminations, establishments, increases or decreases in
benefits, acceleration of payments or vesting schedules or other
events that would result in any liability to any of the Acquired
Corporations or any Company Affiliate; (vii) all
correspondence to or from any Governmental Body relating to any
Company Employee Plan; (viii) all COBRA forms and related
notices; (ix) all insurance policies pertaining to fiduciary
liability insurance covering the fiduciaries for each Company
Employee Plan; (x) all non-discrimination test reports and
summaries for each Company Employee Plan for the three most recent
plan years; and (xi) the most recent IRS determination or
opinion letter issued with respect to each Company Employee Plan
intended to be qualified under Section 401(a) of the
Code.
(e) Each of the Acquired Corporations and Company
Affiliates has performed all material obligations required to be
performed by it under each Company Employee Plan and Company
Employee Agreement. No Acquired Corporation or Company Affiliate is
in default or violation of, and the Company has no Knowledge of any
default or violation by any other party to, the terms of any
Company Employee Plan or Company Employee Agreement. Each Company
Employee Plan and Company Employee Agreement has been established
and maintained substantially in accordance with its terms and in
substantial compliance with all applicable Legal Requirements,
including ERISA and the Code. Any Company Employee Plan intended to
be qualified under Section 401(a) of the Code has obtained a
favorable determination letter (or opinion letter, if applicable)
as to its qualified status under the Code and incorporates or has
been amended to incorporate all provisions required to comply with
the Tax Reform Act of 1986 and all subsequent legislation. For each
Company Employee Plan that is intended to be qualified under
Section 401(a) of the Code, there has been no event, condition
or circumstance that has adversely affected or is likely to
adversely affect its tax-qualified status. No “prohibited
transaction,” within the meaning of Section 4975 of the
Code or Sections 406 and 407 of ERISA, that is not otherwise exempt
under Section 408 of ERISA, has occurred with respect to any
Company Employee Plan. There are no claims or Legal Proceedings
pending, or, to the Knowledge of the Company, threatened or
reasonably anticipated (other than routine claims for benefits),
against any Company Employee Plan or against the assets of any
Company Employee Plan. Each Company Employee Plan can be amended,
terminated or otherwise discontinued after the Closing in
accordance with its terms, without liability to Parent, any of the
Acquired Corporations or any Company Affiliate (other than ordinary
administration expenses), subject to applicable Legal Requirements.
There are no audits, inquiries or Legal Proceedings pending or, to
the Knowledge of the Company, threatened by the IRS, the DOL, or
any other Governmental Body with respect to any Company Employee
Plan or Company Employee Agreement. No Acquired Corporation, and no
Company Affiliate, has ever incurred any penalty or tax with
respect to any Company Employee Plan under Section 502(i) of
ERISA, under Sections 4975 through 4980 of the Code or under any
other applicable Legal Requirement. Each of the Acquired
Corporations and Company Affiliates has timely made all
contributions and other payments required by and due under the
terms of each Company Employee Plan and Company Employee
Agreement.
(f) Each Company Contract that is a
“nonqualified deferred compensation plan” subject to
Section 409A of the Code has been operated since
January 1, 2005 in good faith compliance with
Section 409A of the Code. No stock right (as defined in U.S.
Treasury Department regulation 1.409A-1(l)) has been granted to any
Company Associate
22.
that (i) has an exercise price that has
been or may be less than the fair market value of the underlying
equity as of the date such option or right was granted, as
determined by the board of directors of the Company in good faith,
(ii) has any feature for the deferral of compensation other
than the deferral of recognition of income until the later of
exercise or disposition of such option or rights, or (iii) has
been granted after December 31, 2004, with respect to any
class of stock that is not “service recipient stock”
(within the meaning of applicable regulations under
Section 409A of the Code). No compensation payable by any of
the Acquired Corporations or any of the Company Affiliates shall be
or has been reportable as nonqualified deferred compensation in the
gross income of any individual or entity as a result of the
operation of Section 409A of the Code.
(g) No Acquired Corporation, and no Company
Affiliate, has ever maintained, established, sponsored,
participated in, or contributed to any: (i) Company Pension
Plan, including but not limited to, a plan which is subject to Part
3 of Subtitle B of Title I of ERISA, Title IV of ERISA or
Section 412 of the Code; (ii) “multiemployer
plan” within the meaning of Section (3)(37) of ERISA;
(iii) Company Pension Plan in which stock of any of the
Acquired Corporations or any Company Affiliate is or was held as a
plan asset, (iv) multiple employer plan or to any plan
described in Section 413 of the Code; or
(vi) self-insured plan that provides benefits to employees
(including any such plan pursuant to which a stop-loss policy or
contract applies).
(h) Neither the execution and delivery of this
Agreement nor the consummation of the transactions contemplated
hereby (either alone or in connection with any other event,
including any termination of employment or service) will
(i) result in any payment (including severance, golden
parachute, bonus or otherwise), becoming due to any Company
Associate under any Company Employee Plan or Company Employee
Agreement, (ii) result in any forgiveness of indebtedness,
(iii) materially increase any benefits otherwise payable by
the Company under any Company Employee Plan or Company Employee
Agreement, (iv) result in the acceleration of the time of
payment or vesting of any such benefits except as required under
Section 411(d)(3) of the Code or (v) be reasonably likely
to result in any payment to any Company Associate being
non-deductible by virtue of Section 280G or Section 4999
of the Code. Part 2.14(h) of the Company Disclosure Schedule sets
forth the Company Employee Plans and Company Employee Agreements
giving rise to the potential “excess parachute
payments” (within the meaning of Section 280G of the
Code) payable by the Company or any of its Subsidiaries in
connection with the transactions contemplated by this Agreement,
either as a result of the transactions contemplated by this
Agreement or in conjunction with any other event.
(i) No Company Employee Plan provides (except at no
cost to the Acquired Corporations or any Company Affiliate), or
reflects or represents any liability of any of the Acquired
Corporations or any Company Affiliate to provide, retiree life
insurance, retiree health benefits or other retiree employee
welfare benefits to any Person for any reason, except as may be
required by COBRA or other applicable Legal Requirements. Other
than commitments made that involve no future costs to any of the
Acquired Corporations or any Company Affiliate, no Acquired
Corporation, and no Company Affiliate, has ever represented,
promised or contracted (whether in oral or written form) to any
Company Employee (either individually or to Company Employees as a
group) or any other Person that any such Company Employee or other
Person would be provided with retiree life insurance, retiree
health benefits or other retiree employee welfare benefits, except
to the extent required by applicable Legal Requirements.
23.
(j) Except as set forth in Part 2.14(j) of the
Company Disclosure Schedule, and except as expressly required or
provided by this Agreement, neither the execution or delivery of
this Agreement nor the consummation of any of the Contemplated
Transactions will (either alone or upon the occurrence of any
additional or subsequent events) constitute an event under any
Company Employee Plan, Company Employee Agreement, trust or loan
that will or may result (either alone or in connection with any
other circumstance or event) in any payment (whether of severance
pay or otherwise), acceleration of any right, obligation or
benefit, forgiveness of indebtedness, vesting, distribution,
increase in benefits or obligation to fund benefits with respect to
any Company Employee.
(k) Except as set forth in Part 2.14(k) of the
Company Disclosure Schedule, no Acquired Corporation, and no
Company Affiliate: (i) has violated or otherwise failed to
comply with any Legal Requirement respecting employment, employment
practices, terms and conditions of employment or wages and hours,
including the health care continuation requirements of COBRA, the
requirements of FMLA, the requirements of HIPAA and the provisions
of any similar Legal Requirement; (ii) has failed to withhold
or report any amounts required by applicable Legal Requirements or
by Contract to be withheld or reported with respect to wages,
salaries and other payments to Company Employees; (iii) is
liable for any arrears of wages or any taxes or any penalty for
failure to comply with the Legal Requirements applicable to any of
the foregoing; and (iv) is liable for any payment to any trust
or other fund governed by or maintained by or on behalf of any
Governmental Body with respect to unemployment compensation
benefits, social security or other benefits or obligations for
Company Employees (other than routine payments to be made in the
normal course of business and consistent with past practice). There
are no pending or, to the Knowledge of the Company, threatened or
reasonably anticipated claims or Legal Proceedings against any of
the Acquired Corporations or any Company Affiliate under any
worker’s compensation policy or long-term disability
policy.
(l) To the Knowledge of the Company, no stockholder
of the Company, and no current Company Associate, is obligated
under any Contract or subject to any Order that would interfere
with such Person’s efforts to promote the interests of the
Acquired Corporations or that would interfere with the businesses
of the Acquired Corporations or any Company Affiliate. Neither the
execution nor the delivery of this Agreement, nor the carrying on
of the business of any of the Acquired Corporations or any Company
Affiliate as presently conducted nor any activity of such
stockholder or current Company Associate in connection with the
carrying on of the business of the Acquired Corporations or any
Company Affiliate as presently conducted will, to the Knowledge of
the Company, conflict with, result in a breach of the terms,
conditions or provisions of, or constitute a default under, any
Contract under which any of such stockholders or current Company
Associate has any rights or obligations.
2.15 Environmental Matters .
(a) Since December 31, 2005, none of the
Acquired Corporations has received any notice or other
communication, whether from a Governmental Body,
citizens
24.
group, Company Associate or otherwise, that
alleges that any of the Acquired Corporations is not or might not
be in compliance with any Environmental Law, and, to the Knowledge
of the Company, there are no circumstances that may prevent or
interfere with the compliance by any of the Acquired Corporations
with any Environmental Law in the future.
(b) To the Knowledge of the Company, and except as
would not reasonably be expected to have or result in a Company
Material Adverse Effect: (i) all property that is or was
leased to or controlled, owned or used by any of the Acquired
Corporations, and all surface water, groundwater, soil and soil
vapors associated with or adjacent to such property, is free of any
Materials of Environmental Concern (as defined in
Section 2.15(d)) or material environmental contamination of
any nature; (ii) none of the property that is or was leased to
or controlled, owned or used by any of the Acquired Corporations
contains any above ground or underground storage tanks, waste
treatment systems, asbestos, equipment using PCBs or underground
injection wells; and (iii) none of the property that is or was
leased to or controlled, owned or used by any of the Acquired
Corporations contains any tanks or sumps in which process
wastewater or any Materials of Environmental Concern have been
Released (as defined in Section 2.15(d)).
(c) No Acquired Corporation has ever sent or
transported, or arranged to send or transport, any Materials of
Environmental Concern to a site that, pursuant to any applicable
Environmental Law: (i) has been placed on the “National
Priorities List” of hazardous waste sites or any similar
state list; (ii) is otherwise designated or identified as a
potential site for remediation, cleanup, closure or other
environmental remedial activity; or (iii) is subject to a
Legal Requirement to take “removal” or
“remedial” action as detailed in any applicable
Environmental Law or to make payment for the cost of investigating
or conducting any removal or remedial actions at such
site.
(d) For purposes of this Agreement: (i) “
Environmental Law ” means any federal, state, local or
foreign Legal Requirement relating to pollution or protection of
human health or the environment (including ambient air, surface
water, ground water, land surface or subsurface), including any
Legal Requirement relating to emissions, discharges, releases or
threatened releases of Materials of Environmental Concern, or
otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of
Materials of Environmental Concern; (ii) “ Materials
of Environmental Concern ” include chemicals, pollutants,
contaminants, wastes, toxic substances, petroleum and petroleum
products and any other substance that is now or hereafter regulated
by any Environmental Law or that is otherwise a danger to health,
reproduction or the environment; and (iii) “
Release ” means any spilling, leaking, emitting,
discharging, depositing, escaping, leaching, dumping or other
releasing into the environment, whether intentional or
unintentional.
2.16 Insurance . All fire and casualty,
general liability, business interruption, product liability,
sprinkler and water damage insurance policies and other forms of
insurance maintained by any of the Acquired Corporations have been
provided or made available to Parent. To the Knowledge of the
Company, each such policy is in full force and effect. All premiums
due thereon have been paid in full.
25.
2.17 Related Party Transactions. Except as set
forth in Part 2.17 of the Company Disclosure Schedule: (a) no
Related Party has, and no Related Party has had, any direct or
indirect interest in any material asset used in or otherwise
relating to the business of any of the Acquired Corporations;
(b) no Related Party is, or has been, indebted to any of the
Acquired Corporations; (c) no Related Party has entered into,
or has had any direct or indirect financial interest in, any
Company Material Contract, transaction or business dealing
involving any of the Acquired Corporations; (d) no Related
Party is competing, or has competed, directly or indirectly, with
any of the Acquired Corporations; and (e) no Related Party has
any claim or right against any of the Acquired Corporations (other
than rights under Company Options and rights to receive
compensation for services performed as an employee of the Company).
(For purposes of this Agreement, each of the following shall be
deemed to be a “ Related Party ”: (i) each
individual who is, or who has at any time been, an officer or
director of any of the Acquired Corporations; (ii) each member
of the immediate family of each of the Persons referred to in
clause “(i)” above; and (iii) any trust or other
Entity (other than the Company) in which any one of the Persons
referred to in clauses “(i)” and “(ii)”
above holds (or in which more than one of such individuals
collectively hold), beneficially or otherwise, a material voting,
proprietary or equity interest).
2.18 Legal Proceedings;
Orders .
(a) Except as set forth in Part 2.18(a) of the
Company Disclosure Schedule, there is no pending Legal Proceeding,
and (to the Knowledge of the Company) no Person has threatened to
commence any Legal Proceeding: (i) that involves any of the
Acquired Corporations, any business of any of the Acquired
Corporations or any of the assets owned, leased or used by any of
the Acquired Corporations; or (ii) that challenges, or that
may have the effect of preventing, delaying, making illegal or
otherwise interfering with, the Merger or any of the other
Contemplated Transactions. None of the Legal Proceedings identified
in Part 2.18(a) of the Company Disclosure Schedule has had or, if
adversely determined, would reasonably be expected to have or
result in a Company Material Adverse Effect. To the Knowledge of
the Company, no event has occurred, and no claim, dispute or other
condition or circumstance exists, that would reasonably be expected
to give rise to or serve as a basis for the commencement of any
Legal Proceeding of the type described in clause “(i)”
or clause “(ii)” of the first sentence of this
Section 2.18(a) .
(b) There is no Order to which any of the Acquired
Corporations, or any of the assets owned or used by any of the
Acquired Corporations, is subject. To the Knowledge of the Company,
no officer or other key employee of any of the Acquired
Corporations is subject to any Order that prohibits such officer or
other employee from engaging in or continuing any conduct, activity
or practice relating to the business of any of the Acquired
Corporations.
2.19 Authority; Binding Nature of Agreement .
The Company has the corporate right, power and authority to enter
into and, subject to obtaining the Required Company Stockholder
Vote (as defined in Section 2.21), to perform its obligations
under this Agreement. The board of directors of the Company (at a
meeting duly called and held) has: (a) unanimously determined
that the Merger is advisable and fair to, and in the best interests
of, the Company and its stockholders; (b) unanimously
authorized and approved the execution,
26.
delivery and performance of this Agreement by
the Company and unanimously approved the Merger; and
(c) unanimously recommended the adoption of this Agreement by
the holders of Company Capital Stock. This Agreement constitutes
the legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, subject to:
(i) laws of general application relating to bankruptcy,
insolvency and the relief of debtors; and (ii) rules of law
governing specific performance, injunctive relief and other
equitable remedies.
2.20 Inapplicability of Anti-takeover Statutes
. No state takeover statute or similar Legal Requirement applies or
purports to apply to the Merger, this Agreement or any of the
Contemplated Transactions.
2.21 Vote Required . The affirmative vote of a
majority of its outstanding capital stock and the affirmative vote
of a majority of the four entities listed on Schedule 2.21 attached
hereto (collectively, the “ Required Company Stockholder
Vote ”) are the only votes of the holders of any class or
series of the Company’s capital stock necessary to adopt this
Agreement. The stockholders of the Company that have entered into
and delivered Company Voting Agreements with and in favor of the
Parent together hold sufficient shares of Company Capital Stock to
deliver the Required Company Stockholder Vote in accordance with
such Company Voting Agreements.
2.22 Non-Contravention; Consents . Except as
set forth in Part 2.22 of the Company Disclosure Schedule, neither
(1) the execution, delivery or performance of this Agreement
or any of the other Contracts referred to in this Agreement, nor
(2) the consummation of the Merger or any of the other
Contemplated Transactions will directly or indirectly (with or
without notice or lapse of time):
(a) contravene, conflict with or result in a
violation of (i) any of the provisions of the certificate of
incorporation, bylaws or other charter or organizational documents
of any of the Acquired Corporations, or (ii) any resolution
adopted by the stockholders, the board of directors or any
committee of the board of directors of any of the Acquired
Corporations;
(b) contravene, conflict with or result in a
violation of, or give any Governmental Body or other Person the
right to challenge the Merger or any of the other Contemplated
Transactions or to exercise any remedy or obtain any relief under,
any Legal Requirement or any Order to which any of the Acquired
Corporations, or any of the assets owned or used by any of the
Acquired Corporations, is subject;
(c) contravene, conflict with or result in a
violation of any of the terms or requirements of, or give any
Governmental Body the right to revoke, withdraw, suspend, cancel,
terminate or modify, any Governmental Authorization that is held by
any of the Acquired Corporations or that otherwise relates to the
business of any of the Acquired Corporations or to any of the
assets owned or used by any of the Acquired
Corporations;
(d) contravene, conflict with or result in a
violation or breach of, or result in a default under, any provision
of any Company Contract that constitutes a Company Material
Contract, or give any Person the right to (i) declare a
default or exercise any remedy
27.
under any such Company Contract, (ii) a
rebate, chargeback, penalty or change in delivery schedule under
any such Company Contract, (iii) accelerate the maturity or
performance of any obligation under any such Company Contract, or
(iv) cancel, terminate or modify any term of any such Company
Contract; or
(e) result in the imposition or creation of any
Encumbrance upon or with respect to any asset owned or used by any
of the Acquired Corporations (except for minor liens that will not,
in any case or in the aggregate, materially detract from the value
of the assets subject thereto or materially impair the operations
of any of the Acquired Corporations).
Except as may be required by the
DGCL and except as set forth in Part 2.22 of the Company Disclosure
Schedule, none of the Acquired Corporations was, is or will be
required to make any filing with or give any notice to, or to
obtain any Consent from, any Person in connection with (x) the
execution, delivery or performance of this Agreement or any of the
other Contemplated Transactions, or (y) the consummation of
the Merger or any of the other Contemplated Transactions. (For
purposes of this Agreement, an Acquired Corporation will be deemed
to be or to have been “required” to obtain a Consent if
the failure to obtain such Consent (1) could result in the
imposition of any liability or obligation on, or the expansion of
any liability or obligation of, any of the Acquired Corporations,
(2) could result in the termination, modification or
limitation of any contractual or other right of any of the Acquired
Corporations, or (3) could otherwise have an adverse effect on
the business, condition, capitalization, assets, Intellectual
Property, liabilities, results of operations, financial performance
or prospects of any of the Acquired Corporations.
2.23 Financial Advisor . Except for J.P.
Morgan and Cowen and Company, LLC, no broker, finder or investment
banker is entitled to any brokerage, finder’s or other fee or
commission in connection with the Merger or any of the other
Contemplated Transactions based upon arrangements made by or on
behalf of any of the Acquired Corporations. The Company has
furnished to Parent accurate and complete copies of all agreements
under which any such fees, commissions or other amounts have been
paid or may become payable and all indemnification and other
agreements related to the engagement of J.P. Morgan and Cowen and
Company, LLC.
2.24 Full Disclosure .
(a) To the Company’s Knowledge, this Agreement
(including the Company Disclosure Schedule) does not, and the
certificate referred to in Section 6.7 will not:
(i) contain any representation, warranty or information that
is false, misleading or incomplete with respect to any material
fact; or (ii) omit to state any material fact necessary in
order to make the representations, warranties and information
contained and to be contained herein and therein (in the light of
the circumstances under which such representations, warranties and
information were or will be made or provided) not false or
misleading.
(b) None of the information supplied or to be
supplied by or on behalf of the Company for inclusion or
incorporation by reference in the Form S-4 Registration Statement
will, at the time the Form S-4 Registration Statement is filed with
the SEC or at the time it becomes effective under the Securities
Act, contain any untrue statement of a material
28.
fact or omit to state any material fact required
to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they are
made, not misleading. None of the information supplied or to be
supplied by or on behalf of the Company for inclusion or
incorporation by reference in the Proxy Statement/Prospectus will,
at the time the Proxy Statement/Prospectus is mailed to the
stockholders of Parent or at the time the Company Written Consent
is executed by Company stockholders sufficient to provide the
Required Company Stockholder Vote) or at the time of the Parent
Stockholders’ Meeting (or any adjournment or postponement
thereof), contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or
necessary in order to make the statements therein, in the light of
the circumstances under which they are made, not
misleading.
Section 3. R
EPRESENTATIONS
AND W ARRANTIES OF P ARENT AND M ERGER S UB
Parent and Merger Sub represent and
warrant to the Company as follows (it being understood that each
representation and warranty contained in this Section 3 is
subject to: (a) the exceptions and disclosures set forth in
the part or subpart of the Parent Disclosure Schedule corresponding
to the particular Section or subsection in this Section 3 in
which such representation and warranty appears; (b) any
exceptions or disclosures explicitly cross-referenced in such part
or subpart of the Parent Disclosure Schedule by reference to
another part or subpart of the Parent Disclosure Schedule; and
(c) any exception or disclosure set forth in any of the Parent
SEC Documents or other part or subpart of the Parent Disclosure
Schedule to the extent it is readily apparent from the wording of
such exception or disclosure that such exception or disclosure is
intended to qualify such representation and warranty):
3.1 Due Organization .
(a) Part 3.1(a) of the Parent Disclosure Schedule
identifies each Subsidiary of Parent and indicates its jurisdiction
of organization. Neither Parent nor any of the Entities identified
in Part 3.1(a) of the Parent Disclosure Schedule owns any capital
stock of, or any equity interest of any nature in, any other
Entity, other than the Entities identified in Part 3.1(a) of the
Parent Disclosure Schedule. None of the Acquiring Corporations has
agreed or is obligated to make, or is bound by any Contract under
which it may become obligated to make, any future investment in or
capital contribution to any other Entity.
(b) Parent is a corporation duly organized, validly
existing and in good standing under the laws of the State of
Delaware, Merger Sub is a corporation duly organized, validly
existing and in good standing under the laws of the State of
Delaware, and Parent and Merger Sub have all necessary power and
authority: (i) to conduct their businesses in the manner in
which their businesses are currently being conducted; (ii) to
own and use their assets in the manner in which their assets are
currently owned and used; and (iii) to perform their
obligations under all Contracts by which they are bound.
(c) Each of Parent and Merger Sub (in jurisdictions
that recognize the following concepts) is qualified to do business
as a foreign corporation, and is in good standing, under the laws
of all jurisdictions where the nature of its business requires such
qualification, except as would not have and would not reasonably be
expected to have or result in a Parent Material Adverse
Effect.
29.
3.2 Certificate of Incorporation and Bylaws.
The copies of the certificate of incorporation and bylaws of Parent
which are incorporated by reference as exhibits to the
Parent’s Annual Report on Form 10-K for the year ended
December 31, 2007 are complete and correct copies of such
documents and contain all amendments thereto as in effect on the
date of this Agreement. Parent has delivered to the Company
accurate and complete copies of: (a) the certificate of
incorporation, bylaws and other charter and organizational
documents of each Acquiring Corporation, including all amendments
thereto; and (b) the minutes and other records of the meetings
and other proceedings (including any actions taken by written
consent or otherwise without a meeting) of the stockholders of each
Acquiring Corporation, the board of directors of each Acquiring
Corporation and all committees of the board of directors of each
Acquiring Corporation.
3.3 Capitalization, Etc .
(a) The authorized capital stock of Parent consists
of (i) 100,000,000 shares of Parent Common Stock and
(ii) 5,000,000 shares of Parent Preferred Stock. As of the
close of business on September 15, 2008: (A) 53,663,805
shares of Parent Common Stock were issued and outstanding;
(B) no shares of Parent Preferred Stock were issued or
outstanding; (C) no shares of Parent Common Stock were held by
Parent in its treasury; (D) there were outstanding Parent
Options to purchase 5,594,298 shares of Parent Common Stock,
outstanding restricted stock units pursuant to which 27,332 shares
of Parent Common Stock are issuable, and 6,806,216 shares of Parent
Common Stock were reserved for issuance under the Parent Stock
Plans (not including shares issuable pursuant to Parent Options and
restricted stock units); and (E) there were outstanding
warrants (“ Parent Warrants ”) exercisable for
850,224 shares of Parent Common Stock and such number of shares of
Parent Common Stock were reserved for issuance upon conversion of
such Parent Warrants. Such issued and outstanding shares of Parent
Common Stock have been duly authorized and validly issued, are
fully paid and nonassessable, and are free of preemptive rights.
During the period from September 15, 2008 to the date of this
Agreement, (i) there have been no issuances by Parent of
shares of capital stock of Parent other than issuances of capital
stock of Parent pursuant to the exercise of Parent Options
outstanding on such date and (ii) there have been no issuances
of Parent Options or other options, warrants or other rights to
acquire capital stock of Parent. Parent has not, subsequent to
September 15, 2008, declared or paid any dividend, or declared
or made any distribution on, or authorized the creation or issuance
of, or issued, or authorized or effected any split-up or any other
recapitalization of, any of its capital stock, or directly or
indirectly redeemed, purchased or otherwise acquired any of its
outstanding capital stock. Parent has not heretofore agreed to take
any such action, and there are no outstanding contractual
obligations of Parent of any kind to redeem, purchase or otherwise
acquire any outstanding shares of capital stock of Parent. Other
than the Parent Common Stock, there are no outstanding bonds,
debentures, notes or other indebtedness or securities of Parent
having the right to vote (or, other than the outstanding Parent
Options and warrants, convertible into, or exchangeable for,
securities having the right to vote) on any matters on which
stockholders of Parent may vote.
(b) Except as set forth in Section 3.3(a),
(i) as of September 15, 2008, no shares of capital stock
or other voting securities of Parent are issued, reserved for
issuance or outstanding, and (ii) there are no outstanding
securities, options, warrants, calls, rights, commitments,
agreements, arrangements or undertakings of any kind to which
Parent or any of
30.
Parent Subsidiaries is a party or by which any
of them is bound obligating Parent or any of the Parent
Subsidiaries to issue, deliver or sell, or cause to be issued,
delivered or sold, additional shares of capital stock or other
voting securities of Parent or of any of the Parent Subsidiaries or
obligating Parent or any of the Parent Subsidiaries to issue,
grant, extend or enter into any such security, option, warrant,
call, right, commitment, agreement, arrangement or
undertaking.
(c) All outstanding shares of Parent Common Stock,
and all options and other securities of Parent have been issued and
granted in compliance with: (i) all applicable securities laws
and other applicable Legal Requirement applicable to Parent; and
(ii) all material requirements set forth in applicable
Contracts.
3.4 SEC Filings; Financial Statements
.
(a) Parent has delivered (or made available on the
SEC website) to the Company accurate and complete copies of all
registration statements, proxy statements and other statements,
reports, schedules, forms and other documents filed by Parent with,
and all Parent Certifications (as defined below) filed or furnished
by Parent with or to, the SEC since December 31, 2005,
including all amendments thereto (collectively, the “
Parent SEC Documents ”). All statements, reports,
schedules, forms and other documents required to have been filed or
furnished by Parent with or to the SEC since December 31, 2005
have been so filed or furnished on a timely basis. None of
Parent’s Subsidiaries is required to file or furnish any
documents with or to the SEC. As of the time it was filed with or
furnished to the SEC: (i) each of the Parent SEC Documents
complied as to form in all material respects with the applicable
requirements of the Securities Act or the Exchange Act (as the case
may be); and (ii) none of the Parent SEC Documents contained
any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except to the extent
corrected by the filing or furnishing of the applicable amending or
superseding Parent SEC Document. Each of the certifications and
statements relating to Parent SEC Documents required by:
(1) the SEC’s Order dated June 27, 2002 pursuant to
Section 21(a)(1) of the Exchange Act (File No. 4-460);
(2) Rule 13a-14 or 15d-14 under the Exchange Act; or
(3) 18 U.S.C. §1350 (Section 906 of the Sarbanes-Oxley
Act) (collectively, the “ Parent Certifications
”) is accurate and complete, and complied as to form and
content with all applicable Legal Requirements in effect at the
time such Parent Certification was filed with or furnished to the
SEC.
(b) Parent and its Subsidiaries maintain disclosure
controls and procedures required by Rule 13a-15 or 15d-15 under the
Exchange Act. Such disclosure controls and procedures are designed
to ensure that all material information concerning Parent required
to be disclosed by Parent in the reports that it is required to
file, submit or furnish under the Exchange Act is recorded,
processed, summarized and reported on a timely basis to the
individuals responsible for the preparation of such
reports.
(c) The financial statements (including any related
notes) contained or incorporated by reference in the Parent SEC
Documents: (i) complied as to form in all material respects
with the published rules and regulations of the SEC applicable
thereto; (ii) were prepared in accordance with GAAP applied on
a consistent basis throughout the periods covered (except as may be
indicated in the notes to such financial statements or, in the case
of unaudited
31.
financial statements, as permitted by Form 10-Q,
Form 8-K or any successor form under the Exchange Act, and except
that the unaudited financial statements may not contain footnotes
and are subject to normal and recurring year-end adjustments that
will not, individually or in the aggregate, be material in amount),
and (iii) fairly present in all material respects the
consolidated financial position of Parent and its Subsidiaries as
of the respective dates thereof and the consolidated results of
operations and cash flows of Parent and its Subsidiaries for the
periods covered thereby. The Acquiring Corporations’ Net Cash
as of August 31, 2008 was $64,800,000.
(d) To the Knowledge of Parent, Parent’s
auditor has at all times since the date of enactment of the
Sarbanes-Oxley Act been: (i) a registered public accounting
firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley
Act); (ii) “independent” with respect to Parent
within the meaning of Regulation S-X under the Exchange Act; and
(iii) in compliance with subsections (g) through
(l) of Section 10A of the Exchange Act and the rules and
regulations promulgated by the SEC and the Public Company
Accounting Oversight Board thereunder. All non-audit services (as
defined in Section 2(a)(8) of the Sarbanes-Oxley Act)
performed by Parent’s auditors for Parent or any of its
Subsidiaries were approved as required by Section 202 of the
Sarbanes-Oxley Act.
3.5 Absence of Changes. Except as set forth
in Part 3.5 of the Parent Disclosure Schedule, between
December 31, 2007 and the date of this Agreement:
(a) there has not been any Parent Material Adverse Effect, and
no event has occurred or circumstance has arisen that, in
combination with any other events or circumstances, would
reasonably be expected to have or result in a Parent Material
Adverse Effect; (b) there has not been any material loss,
damage or destruction to, or any material interruption in the use
of, any of the assets of the Acquiring Corporations (whether or not
covered by insurance); (c) none of the Acquiring Corporations
has made any capital expenditure which, when added to all other
capital expenditures made on behalf of the Acquiring Corporations
since December 31, 2007, exceeds $500,000 in the aggregate;
(d) none of the Acquiring Corporations has written off as
uncollectible, or established any extraordinary reserve with
respect to, any account receivable or other indebtedness;
(e) none the Acquiring Corporations has entered into any
material transaction or taken any other material action outside the
ordinary course of business or inconsistent with past practices;
(f) none of the Acquiring Corporations has taken any action of
the type referred to in Section 4.2(b); and (g) none of
the Acquiring Corporations has agreed or committed to take any of
the actions referred to in clauses “(c)” through
“(f)” of this sentence.
3.6 Title to Assets. The Acquiring
Corporations own, and have good, valid and marketable title to, all
assets purported to be owned by them, including: (a) all
assets reflected on the unaudited consolidated balance sheet
included in Parent’s quarterly report on Form 10-Q for the
quarter ending on June 30, 2008 as filed with the SEC on
July 24, 2008 (the “ Parent June 2008 Balance
Sheet ”), (except for inventory sold or otherwise
disposed of in the ordinary course of business since the date of
the Parent June 2008 Balance Sheet); and (b) all other assets
reflected in the books and records of the Acquiring Corporations as
being owned by them. All of said assets are owned by the Acquiring
Corporations free and clear of any Encumbrances, except for
(i) any lien for current taxes not yet due and payable,
(ii) minor liens that have arisen in the ordinary course of
business and that do not (in any case or in the aggregate)
materially detract from the value of the assets subject thereto or
materially impair the
32.
operations of the Acquiring Corporations, and
(iii) liens described in Part 3.6 of the Parent Disclosure
Schedule. the Acquiring Corporations are the lessees of, and hold
valid leasehold interests in, all assets purported to have been
leased by them, including: (A) all assets reflected as leased
on the Parent June 2008 Balance Sheet; and (B) all other
assets reflect